摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-bromo-1,7-dimethoxynaphthalene | 2059-68-9

中文名称
——
中文别名
——
英文名称
4-bromo-1,7-dimethoxynaphthalene
英文别名
4-Brom-1,7-dimethoxy-naphthalin;1-Bromo-4,6-dimethoxynaphthalene;1-bromo-4,6-dimethoxynaphthalene
4-bromo-1,7-dimethoxynaphthalene化学式
CAS
2059-68-9
化学式
C12H11BrO2
mdl
——
分子量
267.122
InChiKey
QYTAVUPAUOYWOJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    71 °C
  • 沸点:
    364.4±22.0 °C(Predicted)
  • 密度:
    1.422±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2909309090

SDS

SDS:37ce8485c29d7fc58a18657da4d3bc99
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis and biological activity of some known and putative duloxetine metabolites
    摘要:
    Several putative phase I duloxetine metabolites, 4-hydroxy-, 5-hydroxy-, 6-hydroxy-, 5-hydroxy-6-methoxy-, 6-hydroxy5-methoxy-, 5,6-dihydroxy-, and 4,6-dihydroxyduloxetine were synthesized, and their phase II metabolite as glucuronide or sulfate conjugates were also synthesized. Their in vitro binding activities were compared to that of parent compound duloxetine. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.04.066
  • 作为产物:
    参考文献:
    名称:
    Synthesis and biological activity of some known and putative duloxetine metabolites
    摘要:
    Several putative phase I duloxetine metabolites, 4-hydroxy-, 5-hydroxy-, 6-hydroxy-, 5-hydroxy-6-methoxy-, 6-hydroxy5-methoxy-, 5,6-dihydroxy-, and 4,6-dihydroxyduloxetine were synthesized, and their phase II metabolite as glucuronide or sulfate conjugates were also synthesized. Their in vitro binding activities were compared to that of parent compound duloxetine. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.04.066
点击查看最新优质反应信息

文献信息

  • 안트라센 유도체 및 이를 포함하는 유기 발광 소자
    申请人:SFC CO., LTD. 에스에프씨 주식회사(120060087061) Corp. No ▼ 135511-0105889BRN ▼134-81-54429
    公开号:KR20150043020A
    公开(公告)日:2015-04-22
    본 발명은 안트라센 유도체 및 이를 포함하는 유기 발광 소자에 관한 것으로서, 보다 상세하게는, 하기 화학식 A로 표시되는 유기발광소자용 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. [화학식 A] 상기 [화학식 A] 에서, R, R, m, n, X 내지 X은 발명의 상세한 설명에 기재된 바와 같다.
    本发明涉及蒽衍生物及含有其的有机发光器件,更详细地说,涉及用化学式A表示的有机发光器件用化合物及含有其的有机发光器件。在上述化学式A中,R、R、m、n、X到X如本发明的详细描述中所述。
  • Synthesis and biological activity of some known and putative duloxetine metabolites
    作者:F. Kuo、T.A. Gillespie、P. Kulanthaivel、R.J. Lantz、T.W. Ma、D.L. Nelson、P.G. Threlkeld、W.J. Wheeler、P. Yi、M. Zmijewski
    DOI:10.1016/j.bmcl.2004.04.066
    日期:2004.7
    Several putative phase I duloxetine metabolites, 4-hydroxy-, 5-hydroxy-, 6-hydroxy-, 5-hydroxy-6-methoxy-, 6-hydroxy5-methoxy-, 5,6-dihydroxy-, and 4,6-dihydroxyduloxetine were synthesized, and their phase II metabolite as glucuronide or sulfate conjugates were also synthesized. Their in vitro binding activities were compared to that of parent compound duloxetine. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多